Stock listing
AB3A Stock Price, News, Filings & Events — Sarepta Therapeutics, Inc.
Selected listing: AB3A · DUS · EUR · DE
This page tracks Sarepta Therapeutics, Inc.'s AB3A:DUS listing on DUS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AB3A:DUS. AB3A:DUS is the stock-level entry point for investors researching Sarepta Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Sarepta Therapeutics, Inc. (SRPT) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
- Ticker
- AB3A:DUS
- Asset type
- Stock
- Market cap
- $2.12B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- DUS
- Currency
- EUR
Sarepta Therapeutics, Inc. AB3A:DUS stock context
This page tracks Sarepta Therapeutics, Inc.'s AB3A:DUS listing on DUS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AB3A:DUS. AB3A:DUS is the stock-level entry point for investors researching Sarepta Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Sarepta Therapeutics, Inc. (SRPT) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Sarepta Therapeutics, Inc.
Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for the 2026-2027 Academic Year
September 8, 2026
Sarepta Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
August 31, 2026
Sarepta Therapeutics Announces Second Quarter 2026 Financial Results and Recent Corporate Developments
August 5, 2026
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
July 30, 2026
Sarepta Therapeutics Appoints Michael Severino, M.D., Chief Executive Officer
July 27, 2026
Sarepta Therapeutics, Inc. earnings calls
Sarepta Therapeutics, Inc. (SRPT) Q2 2026 Earnings Call
August 5, 2026 · Replay with transcript and chapters
Sarepta Therapeutics, Inc. (SRPT) Q1 2026 Earnings Call
May 6, 2026 · Replay with transcript and chapters
Sarepta Therapeutics, Inc. (SRPT) Q4 2025 Earnings Call
February 25, 2026 · Replay with transcript and chapters
Sarepta Therapeutics, Inc. (SRPT) Q3 2025 Earnings Call
November 3, 2025 · Replay with transcript and chapters
Sarepta Therapeutics, Inc. (SRPT) Q1 2025 Earnings Call
May 6, 2025 · Replay with transcript and chapters
Sarepta Therapeutics, Inc. (SRPT) Q4 2024 Earnings Call
February 26, 2025 · Replay with transcript and chapters
Research Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for AB3A:DUS.
Sarepta Therapeutics, Inc. company profile
View the public company page for Sarepta Therapeutics, Inc. on 6ix.
Sarepta Therapeutics, Inc. news
Read company news and market updates connected to Sarepta Therapeutics, Inc..
Sarepta Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Sarepta Therapeutics, Inc..
Alternate listings
SRPT:NASDAQ
US · USD
Alternate listing for Sarepta Therapeutics, Inc.; the primary context on this page is AB3A:DUS.
S1RP34:BMFBOVESPA
BR · BRL
Alternate listing for Sarepta Therapeutics, Inc.; the primary context on this page is AB3A:DUS.
AB3A:GETTEX
DE · EUR
Alternate listing for Sarepta Therapeutics, Inc.; the primary context on this page is AB3A:DUS.
A1J1BH:LSX
DE · EUR
Alternate listing for Sarepta Therapeutics, Inc.; the primary context on this page is AB3A:DUS.
AB3A:TRADEGATE
DE · EUR
Alternate listing for Sarepta Therapeutics, Inc.; the primary context on this page is AB3A:DUS.
SRPT:BMV
MX · MXN
Alternate listing for Sarepta Therapeutics, Inc.; the primary context on this page is AB3A:DUS.
A1J1BH:LS
DE · EUR
Alternate listing for Sarepta Therapeutics, Inc.; the primary context on this page is AB3A:DUS.
0L35:LSE
GB · USD
Alternate listing for Sarepta Therapeutics, Inc.; the primary context on this page is AB3A:DUS.
AB3A:FWB
DE · EUR
Alternate listing for Sarepta Therapeutics, Inc.; the primary context on this page is AB3A:DUS.
SRPT:BOATS
US · USD
Alternate listing for Sarepta Therapeutics, Inc.; the primary context on this page is AB3A:DUS.
1SRPT:MIL
IT · EUR
Alternate listing for Sarepta Therapeutics, Inc.; the primary context on this page is AB3A:DUS.
SRPT:BIVA
MX · MXN
Alternate listing for Sarepta Therapeutics, Inc.; the primary context on this page is AB3A:DUS.